Remembering the forgotten non-communicable diseases

被引:0
作者
Alan D Lopez
Thomas N Williams
Adeera Levin
Marcello Tonelli
Jasvinder A Singh
Peter GJ Burney
Jürgen Rehm
Nora D Volkow
George Koob
Cleusa P Ferri
机构
[1] The University of Melbourne,School of Population and Global Health
[2] Imperial College,Department of Medicine
[3] St Mary’s Hospital,University of British Columbia
[4] KEMRI/Wellcome Trust Research Programme,Medicine Service and Center for Surgical Medical Acute care Research and Transitions
[5] St Paul’s Hospital,Department of Medicine at School of Medicine, and Division of Epidemiology at School of Public Health
[6] 7th Floor,Department of Orthopedic Surgery
[7] TRW Building,National Heart and Lung Institute
[8] VA Medical Center,Clinical Psychology and Psychotherapy
[9] University of Alabama,Addiction Policy, Dalla Lana School of Public Health
[10] Mayo Clinic College of Medicine,Department of Psychiatry
[11] Imperial College,National Institute on Drug Abuse
[12] Centre for Addiction and Mental Health,National Institute on Alcohol Abuse and Alcoholism
[13] Technical Universität Dresden,Institute of Education and Health Sciences
[14] University of Toronto (UofT),Department of Psychobiology, Escola Paulista de Medicina
[15] Faculty of Medicine,undefined
[16] Institute of Medical Science,undefined
[17] National Institutes of Health,undefined
[18] National Institutes of Health,undefined
[19] Hospital Alemao Oswaldo Cruz,undefined
[20] Rua João Julião,undefined
[21] Universidade Federal de São Paulo,undefined
来源
BMC Medicine | / 12卷
关键词
Global health; Non-communicable diseases; Sickle cell disease; Chronic kidney disease; Asthma; Dementia; Gout; Substance abuse; Alcohol; Liver cirrhosis;
D O I
暂无
中图分类号
学科分类号
摘要
The forthcoming post-Millennium Development Goals era will bring about new challenges in global health. Low- and middle-income countries will have to contend with a dual burden of infectious and non-communicable diseases (NCDs). Some of these NCDs, such as neoplasms, COPD, cardiovascular diseases and diabetes, cause much health loss worldwide and are already widely recognised as doing so. However, 55% of the global NCD burden arises from other NCDs, which tend to be ignored in terms of premature mortality and quality of life reduction. Here, experts in some of these `forgotten NCDs' review the clinical impact of these diseases along with the consequences of their ignoring their medical importance, and discuss ways in which they can be given higher global health priority in order to decrease the growing burden of disease and disability.
引用
收藏
相关论文
共 591 条
[1]  
Murray CJ(2012)GBD 2010: design, definitions, and metrics Lancet 380 2063-2066
[2]  
Ezzati M(2013)Measuring the global burden of disease N Engl J Med 369 448-457
[3]  
Flaxman AD(2011)Sickle cell disease in Africa: a neglected cause of early child mortality Am J Prev Med 41 S398-405
[4]  
Lim S(2010)Sickle-cell disease Lancet 376 2018-2031
[5]  
Lozano R(2012)A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010 Lancet 380 2224-2260
[6]  
Michaud C(2013)Global epidemiology of sickle haemoglobin in neonates: a contemporary geostatistical model-based map and population estimates Lancet 381 142-151
[7]  
Naghavi M(2012)Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010 Lancet 380 2197-2223
[8]  
Salomon JA(2012)Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010 Lancet 380 2163-2196
[9]  
Shibuya K(2007)Clinical outcomes in children with sickle cell disease living in England: a neonatal cohort in East London Haematologica 92 905-912
[10]  
Vos T(2010)Improved survival of children and adolescents with sickle cell disease Blood 115 3447-3452